Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients-Reference-Cited by-同舟云学术

Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients

Published:2019-06 Issue:6 Volume:4 Page:833-841
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Dekker Shosha E.I.,Ruhaak L. Renee,Romijn Fred P.H.T.M.,Meijer Esther,Cobbaert Christa M.,de Fijter Johan W.,Soonawala Darius,Drenth Joost P.H.,de Fijter Johan W.,Gansevoort Ron T.,Peters Dorien J.M.,Wetzels Jack F.,Zietse Robert

Publisher

Elsevier BV

Subject

Nephrology

Reference23 articles.

1. Prevalence of autosomal dominant polycystic kidney disease in the European Union;Willey;Nephrol Dial Transplant,2017

2. Autosomal dominant polycystic kidney disease;Torres;Lancet,2007

3. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry;Spithoven;Nephrol Dial Transplant,2014

4. Volume progression in autosomal dominant polycystic kidney disease:the major factor determining clinical outcomes;Grantham;Clin J Am Soc Nephrol,2006

5. Diagnostic evaluation as a biomarker in patients with ADPKD;Park;Adv Exp Med Biol,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary beta-2 microglobulin increases whereas TIMP-2 and IGFBP7 decline after unilateral nephrectomy in healthy kidney donors;Scientific Reports;2024-06-05

2. Urinary Kidney Injury Biomarkers Are Associated with Ischemia-Reperfusion Injury Severity in Kidney Allograft Recipients;Clinical Chemistry;2023-06-05

3. The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease;International Journal of Molecular Sciences;2020-11-25

4. Renal ischemia/reperfusion injury: An insight on in vitro and in vivo models;Life Sciences;2020-09